Findings from the interviews offer insight into potential strategies for reducing binge eating among patients who experience ...

Data from a meta-analysis of 8 observational studies accounting for more than 26 million people across the globe were ...

No significant differences in treatment or outcomes were found between most Medicare Advantage (MA) and fee-for-service (FFS) beneficiaries with breast cancer, but Black patients with FFS Medicare ...

Experts at leading health care conferences last month called for further research into the health effects of microplastics ...

Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the ...

None of the eteplirsen-treated patients reached a left ventricular ejection fraction below 50% compared with 22.1% of ...

Despite significant advancements in spinal muscular atrophy (SMA) management, unmet needs persist, especially for patients ...

Several court cases have been filed against the Trump administration over disruptions touching health care, including funding ...

Pediatric patients with prior SARS-CoV-2 infection had a higher risk of adverse postacute kidney outcomes, such as new-onset ...

The combination therapy can be used as first-line treatment for unresectable or metastatic forms of the cancer.

ECHELON-3 (NCT04404283) principal investigator Craig A. Portell, MD, speaks to the significance of this triplet approval from ...

The California-based entities plan to offer new Medicare Advantage (MA) products in select counties by this fall.